A MISC 05451 Academy of Next Wave Investigators banner scaled

About the Next Wave Academy

Target Audience

The Next Wave of Clinical Investigators activity is a unique opportunity for young clinical investigators to engage with international thought leaders in chronic lymphocytic leukemia (CLL) and non-Hodgkin lymphoma (NHL) in an intimate setting that educates these young investigators on tactics to expand their clinical research and impact the future of patient care.

Selected young investigators will be provided:

  • Registration at an in-person 1.5-day conference featuring sessions with leading CLL and NHL faculty on professional development as well as networking opportunities.
  • Travel to attend the conference and 2 nights’ accommodation at the venue hotel.
  • Matching with a mentor in their area of interest for regular touch points throughout the year.
  • Quarterly virtual meetings on professional development topics.
  • Reception to be held in-person at the American Society of Hematology (ASH) 2023 Annual Meeting and Exposition.


The program for the Next Wave Academy Conference is coming soon.

Day 1

4:00 PM – 4:30 PM
Welcome and Introductions

4:30 PM – 5:00 PM

Keynote Presentation: How To Become a Leader in CLL and NHL
John Leonard, MD and Matthew Davids, MD, MMSc

5:00 AM – 6:30 AM

Icebreakers/Trivia and Meet & Greet with Mentors

Discussion of expectations, goals, and objectives for the academy
6:30 PM

Wrap Up and Adjourn

John Leonard, MD and Matthew Davids, MD, MMSc

6:30 PM – 9:00 PM

Welcome Reception and Dinner

10:50 AM – 11:50 AM
Working Session
  • Interactive, open discussion to develop an article or other output that recaps the key findings from the meeting
11:50 AM – 12:00 PM
Closing Remarks, Action Items for 2023, and Adjourn
Sagar Lonial, MD, FACP (Emory University)

Day 1

7:30 AM – 8:00 AM
8:00 AM – 8:05 AM
Welcome and Review of the Agenda
John Leonard, MD and Matthew Davids, MD, MMSc
8:05 AM – 8:35 AM
Moving the Field Forward in CLL (Presentation and Panel Discussion)
  • Review of therapeutic landscape
  • Case presentations
  • Discussion of clinical trial design, clinical impact, and approaches to challenges encountered
8:35 AM – 9:05 AM
Career Development Discussion
Faculty: Tycel Phillips, MD and Jennifer Woyach, MD
  • Navigating the academic career path
  • Networking with future peers and collaborators
  • Fundamentals of clinical trial design
  • Grant writing
9:05 AM – 9:35 AM
Mentor Breakout: Each faculty member will meet with their junior investigators
9:35 AM – 9:45 AM
Coffee Break
9:45 AM – 10:30 AM
Future Direction for the NHL Treatment Landscape (Presentation and Panel Discussion)
Faculty: Jonathon Cohen, MD, MS
  • Review of therapeutic landscape
  • Case presentations
  • Applying the latest data to clinical cases that reflect decision making that takes place in the clinic
10:30 AM – 11:00 AM
Breakout (Industry Presentation)
  • How to work with industry and benefits/tradeoffs (Commercial and Medical)
  • Why participate in ad boards/steering committees, etc
  • Best practices in designing clinical trial protocols
  • Integrating translational evidence-based research findings into practice

11:00 AM – 11:30 AM

Small Group Discussion – led by Nicole Lamanna, MD and Loretta Nastoupil, MD
  • Publication of a manuscript in a peer-reviewed journal
  • Sourcing funding and development of a research grant
  • Congress publication/presentation development

11:30 AM – 12:00 PM

FDA Presentation
12:00 PM – 1:00 PM
1:00 PM – 1:45 PM
Presentation Skills – Panel Discussion (John Leonard, MD and Matthew Davids, MD, MMSc) or Consultant
  • Slide development game
  • Before and After (critique of oral presentation)
1:45 PM – 3:00 PM
Research Presentations
The top 5 abstract presenters chosen based upon expert investigator scoring will present their research.
Each presentation is limited to 10 minutes with 5 minutes for Q&A

3:00 PM – 3:15 PM

Award Presentation
3:15 PM – 3:35 PM
Mentoring Touchpoint/Wrap Up

3:35 PM – 3:45 PM

Closing Remarks and Next Steps for Academy
John Leonard, MD and Matthew Davids, MD, MMSc